NUTRAVIT LTD.
Company number 10119499 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
1. Industry Classification
NutraVit Ltd is classified under SIC code 46460, “Wholesale of pharmaceutical goods,” placing it within the UK pharmaceutical and nutraceutical wholesaling sector. The company describes itself as a supplier of premium vitamins, minerals and oils, operating through its own website with direct-to-consumer fulfilment alongside its wholesale classification. This segment sits at the intersection of regulated pharmaceutical distribution and the broader health-and-wellness retail market. Key characteristics of the sector include MHRA oversight of medicinal products, Food Standards Agency and Advertising Standards Authority scrutiny of health claims, import-dependent supply chains for many active ingredients, and a shift from traditional pharmacy distribution toward online channels. NutraVit is registered as a micro-entity and files under FRS 105, meaning it benefits from reduced disclosure requirements and audit exemption.
2. Relative Performance
The company’s balance sheet has expanded markedly since incorporation, with total assets rising from £100 at the 2019/20 period to £431,014 at 31 March 2025. Fixed assets are modest (£33,614), while current assets of £397,400 dominate the balance sheet, consistent with a trading business holding inventory and receivables. However, the accounts state net liabilities of £63,825 at 31 March 2025, an improvement from net liabilities of £185,685 in the prior year. The negative equity position is driven primarily by creditors falling due after more than one year of £495,174, which substantially exceed net current assets.
Because the company files micro-entity, filleted accounts, no turnover, gross profit or operating profit figures are publicly available, so profitability cannot be benchmarked against sector norms. Relative to typical UK pharmaceutical wholesalers, NutraVit is very small: the sector’s leading operators generate turnover in the billions and manage complex national distribution networks, whereas NutraVit reports an average of two employees and a single-site operation in Hemel Hempstead. Against micro-entity benchmarks, its balance sheet size is at the upper end of the category, though its negative shareholders’ funds are a point of weakness compared with the positive equity positions typical of established wholesalers.
3. Sector Trends Impact
Several market conditions directly affect this business. The UK vitamins and supplements market has benefited from sustained consumer interest in preventative health, an ageing population and post-pandemic wellness spending, supporting demand for the type of products NutraVit sells. At the same time, the direct-to-consumer e-commerce model exposed by the company’s website places it in competition with established high-street health retailers, supermarket own-label ranges and large online marketplaces, where price transparency is high.
Regulatory friction is a recurring theme. Divergence between UK and EU rules following Brexit has affected labelling, product authorisation and cross-border movement of goods for wholesalers importing raw materials or finished stock. Advertising restrictions on health claims constrain how such products can be marketed online, increasing compliance costs for smaller operators. Supply-chain volatility and currency movements also affect landed costs for import-dependent supplement businesses.
4. Competitive Positioning
NutraVit is best characterised as a niche player rather than a sector leader. Its scale is microscopic compared with the dominant pharmaceutical wholesalers (such as Alliance Healthcare or Phoenix Group) and even compared with mid-sized supplement distributors. Its competitive strengths lie in specialisation, a direct online sales channel and a balance sheet that has grown its current asset base while reducing its net liability position year on year. The negligible amount of creditors due within one year suggests limited short-term trade creditor pressure.
Its weaknesses are structural: negative shareholders’ funds, a substantial long-term creditor balance, and limited public financial transparency due to filleted reporting. Ownership is concentrated, with a corporate entity holding more than 75% of shares and voting rights, alongside two individual PSCs each holding between 25% and 50%. Against typical competitors, NutraVit lacks the distribution scale, purchasing power and regulatory infrastructure of the major wholesalers, but it may retain agility in niche product selection and online customer relationships.